emtricitabine
J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AF - Nucleoside And Nucleotide Reverse Transcriptase Inhibitors -> J05AF09 - Emtricitabine
Administration category:
Free
Medicine group:
antiviral
Brand name:
Emtriva
Standard dosages
| Weight | ROA | Load | Dosage |
|---|---|---|---|
|
ROA: po |
Load: - |
Dosage: 200mg 1 dd |
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: po | ||||
|
GFR: 10 - 50 |
Comments: elke 2-3 dagen |
|||
|
GFR: <10 |
Comments: elke 4 dagen |
|||
Renal elimination:
86%
Dosage:
dependent on kidney function
Renal function-replacement therapy
CAPD: 200 mg 2x per week, onder controle van de emtricitabineconcentratie
Hemo dialysis: dialized - 200 mg 2x per week, onder controle van de emtricitabineconcentratie, op dialysedagen toedienen na de dialyse
CAV / VVHD: 200 mg 2x per week, onder controle van de emtricitabineconcentratie
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-1894.2
Updated: 06/16/2019 - 20:05
Status: Published